Status:

ACTIVE_NOT_RECRUITING

Respiratory Effect of the LISA Method with Sedation by Propofol Versus Absence of Sedation.

Lead Sponsor:

University Hospital, Grenoble

Conditions:

Respiratory Distress Syndrome in Premature Infant

Eligibility:

All Genders

Phase:

PHASE3

Brief Summary

The investigators propose to evaluate premedication with Propofol compared to a control strategy including a placebo with a possible rescue treatment with ketamine to ensure pain control before LISA P...

Detailed Description

Non-inferiority trial comparing Propofol versus placebo during the intra tracheal Less Invasive Surfactant Administration (LISA) in preterm babies \< 32 weeks of gestation for the need for mechanical ...

Eligibility Criteria

Inclusion

  • Preterm Infants \< 32 wGA (weeks of gestational age)
  • Presenting a RDS (respiratory distress syndrome)
  • in the first 48 hours of life
  • treated by CPAP (continuous positive airway pressure) or BiPAP (Bilevel Positive Airway Pressure)
  • requiring surfactant :
  • FIO2 : (fraction of inspired oxygen)
  • if 28 - 31 SA : FiO2 ≥30% for a duration ≥ 10mn
  • if \<28 SA FIO2 ≥25% for a duration ≥10mn
  • SpO2 (arterial oxygen saturation) : to obtain a SpO2 between ≥88 and ≤ 95%
  • Available IntraVenous line (peripheral, umbilical or central catheter)
  • Recipient of the French Social Security
  • Informed consent form signed

Exclusion

  • Congenital and/or major malformations
  • FIO2 \>60%
  • Silverman score \>6
  • Contraindication to the use of Propofol :
  • Low Blood Pressure with 2 successive measurements (Mean \< Gestational Age expressed in Weeks of Gestation) persisting after one volume expansion,
  • Use of inotropic medication to maintain a normal blood pressure.
  • Use of sedative or analgesic drugs (except paracetamol and ibuprofen) in the previous 24h
  • Coma, convulsions, areactivity at neurological examination

Key Trial Info

Start Date :

October 7 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2026

Estimated Enrollment :

233 Patients enrolled

Trial Details

Trial ID

NCT04016246

Start Date

October 7 2019

End Date

October 1 2026

Last Update

December 12 2024

Active Locations (13)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (13 locations)

1

centre hospitalier deTroyes

Troyes, aube, France, 10000

2

CHU Grenoble Alpes

Grenoble, Isère, France, 38043

3

Chu Amiens

Amiens, France, 80000

4

Chu Angers

Angers, France, 49000